Moderna, Inc. (MRNA)
USD 24.19
(-3.68%)
USD 24.19
(-3.68%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.71 Billion USD | -156.37% |
| 2022 | 8.36 Billion USD | -31.47% |
| 2021 | 12.2 Billion USD | 1733.33% |
| 2020 | -747.06 Million USD | -45.34% |
| 2019 | -514.02 Million USD | -33.6% |
| 2018 | -384.73 Million USD | -50.34% |
| 2017 | -255.91 Million USD | -18.36% |
| 2016 | -216.21 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.17 Billion USD | -641.47% |
| 2024 Q2 | -1.27 Billion USD | -8.85% |
| 2023 Q4 | 217 Million USD | 105.98% |
| 2023 FY | -4.71 Billion USD | -156.37% |
| 2023 Q2 | -1.38 Billion USD | -1846.84% |
| 2023 Q3 | -3.63 Billion USD | -163.04% |
| 2023 Q1 | 79 Million USD | -94.61% |
| 2022 Q2 | 2.19 Billion USD | -39.92% |
| 2022 Q4 | 1.46 Billion USD | 40.46% |
| 2022 FY | 8.36 Billion USD | -31.47% |
| 2022 Q1 | 3.65 Billion USD | -24.88% |
| 2022 Q3 | 1.04 Billion USD | -52.53% |
| 2021 Q1 | 1.22 Billion USD | 548.1% |
| 2021 FY | 12.2 Billion USD | 1733.33% |
| 2021 Q4 | 4.86 Billion USD | 46.05% |
| 2021 Q3 | 3.33 Billion USD | 19.89% |
| 2021 Q2 | 2.78 Billion USD | 127.68% |
| 2020 FY | -747.06 Million USD | -45.34% |
| 2020 Q3 | -233.63 Million USD | -100.18% |
| 2020 Q4 | -272.48 Million USD | -16.63% |
| 2020 Q1 | -124.23 Million USD | 0.01% |
| 2020 Q2 | -116.71 Million USD | 6.05% |
| 2019 Q1 | -131.12 Million USD | 7.28% |
| 2019 Q4 | -124.24 Million USD | -0.85% |
| 2019 Q3 | -123.19 Million USD | 8.78% |
| 2019 Q2 | -135.05 Million USD | -3.0% |
| 2019 FY | -514.02 Million USD | -33.6% |
| 2018 Q3 | -80.33 Million USD | 11.34% |
| 2018 Q1 | -72.37 Million USD | -90.74% |
| 2018 FY | -384.73 Million USD | -50.34% |
| 2018 Q4 | -141.42 Million USD | -76.05% |
| 2018 Q2 | -90.6 Million USD | -25.18% |
| 2017 Q4 | -37.94 Million USD | 44.42% |
| 2017 Q3 | -68.26 Million USD | 14.75% |
| 2017 Q2 | -80.07 Million USD | 0.0% |
| 2017 Q1 | -80.07 Million USD | 0.0% |
| 2017 FY | -255.91 Million USD | -18.36% |
| 2016 FY | -216.21 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -3119.989% |
| Alkermes plc | 355.75 Million USD | 1425.062% |
| Agenus Inc. | -245.76 Million USD | -1818.124% |
| Aptorum Group Limited | -2.82 Million USD | -166788.11% |
| Ardelyx, Inc. | -66.06 Million USD | -7035.181% |
| Dyadic International, Inc. | -6.79 Million USD | -69269.834% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -503532.479% |
| Lantern Pharma Inc. | -15.96 Million USD | -29433.502% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -24672.868% |
| Novavax, Inc. | -545.06 Million USD | -764.856% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -7986.734% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -6288.4% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -25317.75% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -47106.089% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -7892.178% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -1161.676% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -19267.86% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -12524.531% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -2764.365% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -6326.984% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -23131.975% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -7472.083% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -14411.313% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -3457.924% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -970.775% |
| AlloVir, Inc. | -190.41 Million USD | -2375.606% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -2196.432% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -16468.255% |
| Bicycle Therapeutics plc | -180.66 Million USD | -2509.264% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -2532.74% |
| ChromaDex Corporation | -4.93 Million USD | -95363.751% |
| Chimerix, Inc. | -82.09 Million USD | -5642.128% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -10468.721% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -4518.399% |
| CRISPR Therapeutics AG | -153.61 Million USD | -2968.811% |
| Precision BioSciences, Inc. | -61.31 Million USD | -7587.666% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -2829.26% |
| Fortress Biotech, Inc. | -60.63 Million USD | -7674.131% |
| Fortress Biotech, Inc. | -60.63 Million USD | -7674.131% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -5678.377% |
| ImmuCell Corporation | -5.77 Million USD | -81533.388% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -4073.122% |
| Immix Biopharma, Inc. | -15.42 Million USD | -30458.702% |
| Incyte Corporation | 597.59 Million USD | 888.823% |
| Innoviva, Inc. | 179.72 Million USD | 2722.94% |
| IO Biotech, Inc. | -86.08 Million USD | -5376.11% |
| Jaguar Health, Inc. | -41.3 Million USD | -11314.044% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -2981.207% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 9138.616% |
| ContextLogic Inc. | -317 Million USD | -1387.066% |
| MiMedx Group, Inc. | 67.43 Million USD | 7090.021% |
| MEI Pharma, Inc. | 17.77 Million USD | 26615.919% |
| NextCure, Inc. | -62.72 Million USD | -7415.584% |
| Onconetix, Inc. | -37.4 Million USD | -12501.012% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -11840.525% |
| Opthea Limited | -220.24 Million USD | -2040.372% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -9114.401% |
| Vaxcyte, Inc. | -402.26 Million USD | -1071.861% |
| PDS Biotechnology Corporation | -42.94 Million USD | -10877.547% |
| Precigen, Inc. | -95.9 Million USD | -4815.332% |
| Pharming Group N.V. | -10.54 Million USD | -44590.937% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -2238.386% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -19107.106% |
| PureTech Health plc | -65.69 Million USD | -7075.366% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -18687.613% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -2121.28% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -19267.86% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -1728.329% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -17206.704% |
| Acelyrin, Inc. | -381.64 Million USD | -1135.192% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -37583544.338% |
| Summit Therapeutics Inc. | -614.92 Million USD | -666.594% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -13723.642% |
| Senti Biosciences, Inc. | -92.91 Million USD | -4973.236% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -4402.431% |
| Elevation Oncology, Inc. | -45.7 Million USD | -10214.196% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -13314.912% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -35962.187% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -70416.081% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -15954.765% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -55352.3% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -8096.408% |
| Seer, Inc. | -86.27 Million USD | -5363.797% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -6936.346% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -7067.946% |
| ESSA Pharma Inc. | -26.58 Million USD | -17633.576% |
| GlycoMimetics, Inc. | -36.89 Million USD | -12675.269% |
| GT Biopharma, Inc. | -7.59 Million USD | -61950.81% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -1853.091% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -8978.479% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 6701.316% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -8561.938% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -9496.906% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -47287.619% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -722.913% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -131282.386% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -9132.637% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -1819.42% |
| Aptose Biosciences Inc. | -51.2 Million USD | -9105.773% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -4695.624% |
| Soligenix, Inc. | -6.14 Million USD | -76666.117% |
| Century Therapeutics, Inc. | -136.67 Million USD | -3349.108% |
| Kura Oncology, Inc. | -152.63 Million USD | -2988.494% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -5183.687% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -44633.346% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 833742.81% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -828371.002% |
| Autolus Therapeutics plc | -208.38 Million USD | -2162.181% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -6456.511% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -6558.662% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -21655.584% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -1992.786% |
| GRI Bio, Inc. | -13.03 Million USD | -36058.625% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -113914.054% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -3699.039% |
| IGM Biosciences, Inc. | -246.41 Million USD | -1813.025% |
| INmune Bio, Inc. | -30 Million USD | -15609.144% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -4163.787% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -11072.261% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -29433.273% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -29744.92% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -7798.132% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -4559.622% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -1607.192% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -1881.571% |
| Verastem, Inc. | -87.36 Million USD | -5295.63% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -8599.343% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -2821.853% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -3940.872% |
| Histogen Inc. | -10.62 Million USD | -44283.768% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -32895.594% |
| Surrozen, Inc. | -43.04 Million USD | -10852.093% |
| Organovo Holdings, Inc. | -14.67 Million USD | -32031.416% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -92567.056% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -8906.675% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -18559.7% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -17399.443% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -56307.221% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -3020.098% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -9534.951% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -15758.705% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -45149.894% |
| Apollomics, Inc. | -172.6 Million USD | -2631.155% |
| Amarin Corporation plc | -59.11 Million USD | -7874.692% |
| Mesoblast Limited | -87.95 Million USD | -5259.498% |
| Turnstone Biologics Corp. | -55.2 Million USD | -8439.855% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -3107.632% |
| Synaptogenix, Inc. | -6.03 Million USD | -77965.693% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -28984.403% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -5942.041% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -98283.251% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -56004.38% |
| Exelixis, Inc. | 207.76 Million USD | 2368.91% |
| Better Therapeutics, Inc. | -39.76 Million USD | -11756.137% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -3174.794% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -791.742% |
| NLS Pharmaceutics AG | -12.17 Million USD | -38628.136% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -60377.068% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -15230.58% |
| Gritstone bio, Inc. | -138.49 Million USD | -3303.856% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -7212.495% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -117751.473% |
| Avid Bioservices, Inc. | -140.75 Million USD | -3249.129% |
| Insmed Incorporated | -749.56 Million USD | -528.896% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -30934.58% |
| MediWound Ltd. | -6.71 Million USD | -70090.59% |
| OmniAb, Inc. | -50.61 Million USD | -9212.709% |
| Alector, Inc. | -130.39 Million USD | -3515.28% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -4045.123% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -8992.136% |
| Zai Lab Limited | -334.62 Million USD | -1308.762% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -1355.001% |
| Aura Biosciences, Inc. | -76.4 Million USD | -6069.511% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -1909.104% |
| Immunic, Inc. | -93.61 Million USD | -4935.679% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -3368.906% |
| Veracyte, Inc. | -74.4 Million USD | -6235.681% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -61315.794% |
| FibroGen, Inc. | -284.23 Million USD | -1558.504% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -17870.418% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -67224.679% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -24930.938% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 1236.364% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -20800.022% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 9667.494% |
| TG Therapeutics, Inc. | 12.67 Million USD | 37300.126% |
| Galecto, Inc. | -38.34 Million USD | -12192.367% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -24886.749% |
| Fortrea Holdings Inc. | -3.4 Million USD | -138547.059% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -3622.245% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -26974.838% |
| XBiotech Inc. | -24.55 Million USD | -19096.156% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -7212.495% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -7420.74% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -4689.385% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -21900.28% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -8440.938% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | -677.068% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -6806.454% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -8279662.532% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -1980.878% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -21069.847% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -2045.556% |
| NexImmune, Inc. | -32.34 Million USD | -14474.397% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -89069.281% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -33461.407% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 219.233% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -19362.45% |
| Scopus BioPharma Inc. | -11.6 Million USD | -40503.534% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -3936.028% |
| Ainos, Inc. | -13.77 Million USD | -34132.477% |
| Pluri Inc. | -20.88 Million USD | -22467.982% |
| Prothena Corporation plc | -147.02 Million USD | -3106.192% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -4039.772% |
| Celularity Inc. | -196.29 Million USD | -2301.488% |
| Rallybio Corporation | -74.56 Million USD | -6222.086% |
| Cue Biopharma, Inc. | -50.73 Million USD | -9191.782% |
| MeiraGTx Holdings plc | -84.02 Million USD | -5510.102% |
| Omeros Corporation | -117.81 Million USD | -3901.256% |
| Humacyte, Inc. | -110.77 Million USD | -4155.434% |
| Immunocore Holdings plc | -55.28 Million USD | -8426.417% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -26112.189% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -20457.324% |
| Blueprint Medicines Corporation | -506.98 Million USD | -829.812% |
| CalciMedica, Inc. | -34.35 Million USD | -13620.639% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -6865.645% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -3233.687% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -2743.373% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -1564.225% |
| Pulmatrix, Inc. | -14.12 Million USD | -33282.905% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -13293.948% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -5604.397% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -879.651% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -4395.046% |
| Cytokinetics, Incorporated | -526.24 Million USD | -795.782% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -12970.844% |
| Nutriband Inc. | -5.48 Million USD | -85838.562% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -11562.543% |
| Vor Biopharma Inc. | -117.86 Million USD | -3899.559% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 208.395% |
| Evogene Ltd. | -23.87 Million USD | -19641.195% |
| ProKidney Corp. | -35.46 Million USD | -13190.854% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -3836.107% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -59986.242% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | -632.896% |
| CorMedix Inc. | -46.33 Million USD | -10072.807% |
| BioLineRx Ltd. | -60.61 Million USD | -7677.081% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -4533.197% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -11379.082% |
| Atai Life Sciences N.V. | -40.22 Million USD | -11619.372% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -5744.997% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -6141.972% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -1513.328% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -16810.604% |
| MediciNova, Inc. | -8.57 Million USD | -54896.106% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -3723.909% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -56174.244% |
| GeoVax Labs, Inc. | -25.96 Million USD | -18053.977% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -1870.423% |
| Biomea Fusion, Inc. | -117.25 Million USD | -3920.298% |
| PTC Therapeutics, Inc. | -626.6 Million USD | -652.309% |
| Mereo BioPharma Group plc | -29.46 Million USD | -15898.1% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -2977.787% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -2151.624% |
| Absci Corporation | -110.56 Million USD | -4163.517% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -15535.158% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -4574.871% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -1897.991% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 33570.605% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -2342.968% |
| Allakos Inc. | -185.7 Million USD | -2438.489% |
| Imunon, Inc. | -19.51 Million USD | -24055.806% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -4743.068% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 4541.304% |
| BioAtla, Inc. | -123.46 Million USD | -3718.179% |
| NLS Pharmaceutics AG | -12.17 Million USD | -38628.136% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -29219.567% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -1340.423% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -12658.126% |
| XOMA Corporation | -40.83 Million USD | -11445.15% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -4527.466% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -3877.623% |
| aTyr Pharma, Inc. | -50.38 Million USD | -9255.216% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -5276.43% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -3006.241% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -1882.888% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -13322.933% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -58155.499% |
| Akari Therapeutics, Plc | -10 Million USD | -47002.318% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -7001756.665% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 1774.041% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -70628.754% |
| UroGen Pharma Ltd. | -102.24 Million USD | -4510.539% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -4314.147% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -60513.199% |
| Orgenesis Inc. | -55.36 Million USD | -8415.02% |
| Entera Bio Ltd. | -8.88 Million USD | -52931.837% |
| GH Research PLC | -35.58 Million USD | -13146.41% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -22519.962% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -5991.384% |
| Xencor, Inc. | -126.08 Million USD | -3638.688% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -125082.502% |
| Replimune Group, Inc. | -215.79 Million USD | -2084.491% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -22066.279% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 187983.619% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -70628.754% |
| Portage Biotech Inc. | -75.33 Million USD | -6157.051% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -56174.244% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -4777.14% |
| OncoCyte Corporation | -27.78 Million USD | -16868.432% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -35033.976% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -42286.293% |
| Purple Biotech Ltd. | -19.88 Million USD | -23612.274% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -67060.564% |
| scPharmaceuticals Inc. | -54.81 Million USD | -8500.62% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -26827.692% |
| HilleVax, Inc. | -123.56 Million USD | -3714.965% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -46540.942% |
| Tharimmune, Inc. | -9.31 Million USD | -50484.316% |
| Genprex, Inc. | -30.86 Million USD | -15175.209% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -1898.093% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -15564.252% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -264434.231% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -88910.322% |
| OKYO Pharma Limited | -16.82 Thousand USD | -28016964.615% |
| Savara Inc. | -54.69 Million USD | -8518.231% |
| Curis, Inc. | -47.41 Million USD | -9842.421% |
| Daré Bioscience, Inc. | -30.16 Million USD | -15529.253% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -30421.032% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -84547.154% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -15710.833% |
| BeiGene, Ltd. | -881.7 Million USD | -434.644% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -22037.691% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -980.283% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -5870.49% |
| Erasca, Inc. | -125.04 Million USD | -3669.933% |
| bluebird bio, Inc. | -211.91 Million USD | -2124.498% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -94170.629% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 2911.894% |
| DBV Technologies S.A. | -72.72 Million USD | -6381.863% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -94170.629% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -11638.925% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -82688.901% |
| Molecular Templates, Inc. | -8.12 Million USD | -57925.603% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -7706.187% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -4131.636% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -3382.771% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -9737.434% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -3233.121% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -2349.977% |
| MacroGenics, Inc. | -9.05 Million USD | -51942.393% |
| RenovoRx, Inc. | -10.23 Million USD | -45971.149% |
| Adicet Bio, Inc. | -142.65 Million USD | -3204.406% |
| Prime Medicine, Inc. | -198.13 Million USD | -2279.21% |
| Aditxt, Inc. | -32.38 Million USD | -14457.992% |
| Adagene Inc. | -18.94 Million USD | -24780.756% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -64371.808% |
| Quantum-Si incorporated | -95.96 Million USD | -4812.464% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -3860.379% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -32236.912% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 3662.306% |
| SciSparc Ltd. | -5.12 Million USD | -91934.362% |
| Vericel Corporation | -3.18 Million USD | -148045.82% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -3919935.924% |
| Minerva Neurosciences, Inc. | -30 Million USD | -15610.53% |
| Generation Bio Co. | -126.61 Million USD | -3623.186% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -6367.191% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -5617.959% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -1698.276% |
| Invivyd, Inc. | -198.64 Million USD | -2273.101% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -1278.471% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -54167.661% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 20769.999% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -47641.543% |
| 2seventy bio, Inc. | -217.57 Million USD | -2066.659% |
| ADMA Biologics, Inc. | -28.23 Million USD | -16593.226% |
| Clene Inc. | -49.5 Million USD | -9422.463% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -21050.829% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -9435.947% |
| GeoVax Labs, Inc. | -25.96 Million USD | -18053.977% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -1336.906% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -14385.489% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 20848.239% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -4671.654% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -6206.017% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -2831.501% |
| Vir Biotechnology, Inc. | -615.06 Million USD | -666.428% |
| Evaxion Biotech A/S | -22.12 Million USD | -21206.215% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -5738.783% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -2256.199% |
| Trevena, Inc. | -40.28 Million USD | -11600.464% |
| Surrozen, Inc. | -43.04 Million USD | -10852.093% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -6718.642% |
| Cingulate Inc. | -23.53 Million USD | -19929.788% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -68100.231% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -11726.392% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -61036.038% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -5125.585% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -7591.806% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -7822.29% |
| Clearmind Medicine Inc. | -11.95 Million USD | -39331.098% |
| Kronos Bio, Inc. | -112.67 Million USD | -4083.788% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -6712.434% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -185866323.786% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -5388.096% |
| Statera Biopharma, Inc. | -174.4 Million USD | -2602.855% |
| ImmunityBio, Inc. | -583.19 Million USD | -708.305% |
| Korro Bio, Inc. | -81.17 Million USD | -5707.421% |
| Kineta, Inc. | -14.09 Million USD | -33334.995% |
| BioVie Inc. | -32.12 Million USD | -14575.971% |
| Codexis, Inc. | -76.24 Million USD | -6083.106% |
| Celularity Inc. | -196.29 Million USD | -2301.488% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -2097.372% |
| Celcuity Inc. | -63.77 Million USD | -7291.134% |
| Virax Biolabs Group Limited | -6.73 Million USD | -69907.783% |
| Cibus, Inc. | -267.62 Million USD | -1661.407% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -11589.729% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -13063.553% |
| IN8bio, Inc. | -30 Million USD | -15609.668% |
| Kodiak Sciences Inc. | -260.49 Million USD | -1709.659% |
| Annexon, Inc. | -134.23 Million USD | -3411.699% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -3923.386% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -7599.092% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -14844.205% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -1186.972% |
| Eyenovia, Inc. | -27.26 Million USD | -17192.041% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 21933.171% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -881021.495% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -6069.834% |
| Arcellx, Inc. | -70.69 Million USD | -6568.553% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -11275.208% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -3422.748% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -15593.977% |
| Moolec Science SA | -51.78 Million USD | -9002.34% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -8901.165% |
| Geron Corporation | -184.12 Million USD | -2460.189% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -11130.762% |
| Royalty Pharma plc | 1.13 Billion USD | 515.391% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -3367.298% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -52915.12% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -22090.598% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -2645.966% |
| Humacyte, Inc. | -110.77 Million USD | -4155.434% |
| Structure Therapeutics Inc. | -89.62 Million USD | -5159.987% |
| 89bio, Inc. | -142.18 Million USD | -3215.306% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -6735.847% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -45327.387% |
| Genelux Corporation | -28.29 Million USD | -16559.01% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -16118.82% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -2561.487% |
| Notable Labs, Ltd. | -11.26 Million USD | -41750.142% |
| Liquidia Corporation | -78.5 Million USD | -5904.943% |
| Mustang Bio, Inc. | -51.6 Million USD | -9035.305% |
| Immunovant, Inc. | -259.33 Million USD | -1717.719% |
| Quantum-Si incorporated | -95.96 Million USD | -4812.464% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -6370.919% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -24222.79% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -4810.928% |
| Acasti Pharma Inc. | -12.85 Million USD | -36576.262% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -20890.425% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -29433.273% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -2484.529% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -109489.245% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -37702.727% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -15884.538% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -11990.9% |
| PepGen Inc. | -78.62 Million USD | -5895.472% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -15735.265% |
| United Therapeutics Corporation | 984.8 Million USD | 578.676% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -21076.999% |
| Solid Biosciences Inc. | -96.01 Million USD | -4809.65% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -98283.251% |
| Immuneering Corporation | -53.47 Million USD | -8715.891% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -92567.056% |
| Silo Pharma, Inc. | -3.7 Million USD | -127281.891% |
| Belite Bio, Inc | -31.63 Million USD | -14802.63% |
| XOMA Corporation | -40.83 Million USD | -11445.15% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -8571.02% |
| Bionomics Limited | -15.49 Billion USD | 69.572% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -5512.907% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -16067.644% |
| uniQure N.V. | -308.47 Million USD | -1428.148% |
| Cassava Sciences, Inc. | -97.21 Million USD | -4748.946% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -64371.808% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -3719.169% |
| Forte Biosciences, Inc. | -31.47 Million USD | -14876.49% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -57375.868% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -16117.146% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -881021.495% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -17870.418% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -28495.693% |
| Altimmune, Inc. | -88.44 Million USD | -5229.745% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -3009.827% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -16067.644% |
| Compugen Ltd. | -18.75 Million USD | -25035.971% |
| Peak Bio, Inc. | -1259.26 USD | -374346738.62% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -10136.922% |
| Benitec Biopharma Inc. | -21.75 Million USD | -21572.567% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -1291.422% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -5582.668% |
| Zura Bio Limited | -60.36 Million USD | -7709.808% |
| PolyPid Ltd. | -23.86 Million USD | -19652.776% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -29864.404% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -5582.668% |
| Instil Bio, Inc. | -156.08 Million USD | -2920.111% |
| argenx SE | -295.05 Million USD | -1497.679% |
| Immunome, Inc. | -106.8 Million USD | -4313.61% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -10993.331% |
| Verona Pharma plc | -54.36 Million USD | -8570.382% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -4617.916% |
| Shattuck Labs, Inc. | -87.29 Million USD | -5299.895% |
| CervoMed Inc. | -2.17 Million USD | -216947.682% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -3681.759% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -35301.021% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -10723.097% |
| Moolec Science SA | -51.78 Million USD | -9002.34% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -27261486.897% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -3388.819% |
| AnaptysBio, Inc. | -163.61 Million USD | -2781.083% |
| Design Therapeutics, Inc. | -66.86 Million USD | -6950.342% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -5690.159% |
| NeurAxis, Inc. | -14.62 Million USD | -32128.77% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -12343.905% |
| Lumos Pharma, Inc. | -34.03 Million USD | -13750.855% |
| Achilles Therapeutics plc | -69.66 Million USD | -6666.669% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -4617.916% |
| 180 Life Sciences Corp. | -19.93 Million USD | -23546.719% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 156774.278% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -185866323.786% |
| Nutriband Inc. | -5.48 Million USD | -85838.562% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -4581.371% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -9598.192% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -6014.851% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -13776.95% |
| MoonLake Immunotherapeutics | -36 Million USD | -12991.804% |
| Palisade Bio, Inc. | -12.3 Million USD | -38225.203% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -11090.77% |
| Beam Therapeutics Inc. | -132.52 Million USD | -3457.011% |
| Neurogene Inc. | -36.31 Million USD | -12880.147% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -2784.68% |
| AEON Biopharma, Inc. | -52.55 Million USD | -8869.48% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -4703.0% |
| Sesen Bio, Inc. | -19.88 Million USD | -23607.504% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -6485.27% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -37570.123% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -961.623% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -4125.302% |
| Athira Pharma, Inc. | -117.67 Million USD | -3906.051% |
| Vaccinex, Inc. | -20.25 Million USD | -23177.863% |
| HCW Biologics Inc. | -24.99 Million USD | -18760.318% |
| XOMA Corporation | -40.83 Million USD | -11445.15% |
| Nektar Therapeutics | -276.05 Million USD | -1607.625% |
| Arvinas, Inc. | -367.3 Million USD | -1183.42% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -7001756.665% |
| Merus N.V. | -154.93 Million USD | -2942.488% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -4738.445% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -14919.914% |
| Rezolute, Inc. | -68.45 Million USD | -6785.873% |
| Clene Inc. | -49.5 Million USD | -9422.463% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -30463.808% |
| BeyondSpring Inc. | -21.02 Million USD | -22319.861% |
| Synlogic, Inc. | -57.28 Million USD | -8129.461% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -39510.117% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -43443.322% |
| Peak Bio, Inc. | -1259.26 USD | -374346738.62% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -12515.072% |
| Krystal Biotech, Inc. | 10.93 Million USD | 43221.112% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -3194.223% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -1349.998% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -101957.496% |
| MannKind Corporation | -11.93 Million USD | -39387.351% |
| Ikena Oncology, Inc. | -68.16 Million USD | -6815.471% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -22331.596% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -4972.472% |
| Gossamer Bio, Inc. | -179.81 Million USD | -2521.554% |
| CohBar, Inc. | -11.96 Million USD | -39307.734% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -18179.82% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -15535.158% |
| Legend Biotech Corporation | -518.25 Million USD | -809.593% |
| Mural Oncology plc | -207.44 Million USD | -2172.388% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -3698.09% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -25674.034% |
| Disc Medicine, Inc. | -76.42 Million USD | -6067.816% |
| Champions Oncology, Inc. | -7.27 Million USD | -64688.345% |
| REGENXBIO Inc. | -263.49 Million USD | -1689.035% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -44316.914% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -9823.166% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -12310.653% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -4606.329% |
| Vaxart, Inc. | -82.46 Million USD | -5616.365% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 1412479.443% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -12456.433% |
| Cellectis S.A. | -101.05 Million USD | -4564.602% |
| Longeveron Inc. | -21.41 Million USD | -21914.664% |
| Repare Therapeutics Inc. | -93.79 Million USD | -4925.801% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -779.515% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -6523.67% |
| Revolution Medicines, Inc. | -436.36 Million USD | -980.283% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -71639.461% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -15193.278% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -6699.071% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -7182.333% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -47948.109% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 230.235% |
| Denali Therapeutics Inc. | -145.22 Million USD | -3146.02% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -3919935.924% |
| Veru Inc. | -93.15 Million USD | -4960.509% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -17340.527% |
| Cingulate Inc. | -23.53 Million USD | -19929.788% |
| Passage Bio, Inc. | -102.06 Million USD | -4518.761% |
| Context Therapeutics Inc. | -23.96 Million USD | -19571.0% |
| Exicure, Inc. | -16.91 Million USD | -27770.403% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -2395.276% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -12382.788% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -72341.447% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -2452.551% |
| Nuvalent, Inc. | -126.21 Million USD | -3634.778% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -44728.397% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -5325.937% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -15333.473% |
| OmniAb, Inc. | -50.61 Million USD | -9212.709% |
| Anew Medical, Inc. | 1.34 Million USD | 350290.361% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -29279.869% |
| Lipocine Inc. | -16.35 Million USD | -28728.133% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -7000.039% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -7303.219% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -11072.261% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -9727.59% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -23670.864% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -770.562% |
| Ocugen, Inc. | -63.07 Million USD | -7373.287% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -4824.163% |
| Q32 Bio Inc. | -112.96 Million USD | -4073.122% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -27319.73% |
| Alumis Inc. Common Stock | -154.99 Million USD | -2941.428% |
| Equillium, Inc. | -13.33 Million USD | -35250.581% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -7709.032% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -58914.732% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -24906.331% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -7878.741% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -4016.06% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -25550.298% |
| Dominari Holdings Inc. | -22.88 Million USD | -20501.346% |
| Edesa Biotech, Inc. | -8.37 Million USD | -56190.499% |
| vTv Therapeutics Inc. | -20.25 Million USD | -23179.012% |
| Bio-Techne Corporation | 168.1 Million USD | 2904.2% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -1238.87% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 3758.432% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -3769.263% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -12325.209% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -4084.94% |
| Nkarta, Inc. | -117.5 Million USD | -3911.881% |
| BioCardia, Inc. | -11.57 Million USD | -40639.78% |
| Iterum Therapeutics plc | -38.37 Million USD | -12185.32% |